Skip to content

FDA INSPECTIONS

Pass Your FDA Inspections!

Menu
  • accounts
    • create account
    • login
    • my account
    • user profile
  • contact
×
Breaking News:
  • FDA CDRH Issues Letters to Manufacturers of Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
  • The United States and European Union will be able to use each other’s Pharmaceutical Inspections
  • US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue
  • US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.
  • Hospira Warning Letter Issued by US FDA

Industries

Industries 
March 13, 2017April 8, 2018

The United States and European Union will be able to use each other’s Pharmaceutical Inspections

Posted By: fdainspections European Union, FDA, Pharmaceuticals

The United States and the European Union (EU)  amended the  1998 U.S.-EU Mutual Recognition Agreement for Pharmaceutical Inspections. The US and the EU will now

Read more
Industries 
March 12, 2017April 8, 2018

US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue

Posted By: fdainspections Dairy, FDA, Food, Warning Letters

On February 27, 2017, an US Food and Drug Administration (USFDA) Warning Letter was issued to the two owners of DeGrave Dairy. This Warning

Read more
Industries 
March 12, 2017April 8, 2018

US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.

Posted By: fdainspections FDA, HAACP, seafood, Warning Letter

On March 2, 2017, an US Food and Drug Administration (USFDA) Warning Letter was issued to seafood importers,  Lucky Pacific Corp and Kamli International

Read more
Industries 
March 12, 2017April 8, 2018

Hospira Warning Letter Issued by US FDA

Posted By: fdainspections FDA, Pharmaceuticals, Warning Letters

On February 14, 2017, an US Food and Drug Administration (USFDA) Warning Letter was issued to Hospira. This Warning Letter was issued  for significant

Read more
Industries 
October 1, 2016April 8, 2018

FDA Warning Letter Issued to Hebei Yuxing Bio-Engineering Co Ltd

Posted By: fdainspections CDER, cGMP, Data Integrity, FDA, Pharmaceutical, Warning Letter

On September 6, 2016, an US Food and Drug Administration (USFDA) Warning Letter was issued to Hebei Yuxing Bio-Engineering Co Ltd. This Warning Letter

Read more
Industries 
September 11, 2016September 22, 2016

US Food and Drug Administration US FDA Forms

Posted By: fdainspections Documents, FDA, Forms

Compilation of US Food and Drug Administration US FDA Forms Below is a compilation of FDA forms with links to the PDF formats. The

Read more

Recent Posts

  • FDA CDRH Issues Letters to Manufacturers of Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
  • The United States and European Union will be able to use each other’s Pharmaceutical Inspections
  • US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue
  • US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.
  • Hospira Warning Letter Issued by US FDA
Terms and Conditions
Privacy

Newsletter

Copyright © 2021 FDA INSPECTIONS. Theme: ColorNews by ThemeGrill. Powered by WordPress.